Pamicell Ranks High in Search... Stock Price Up 2.56%

As of 2:30 PM on the 20th, Pharmicell is trading at 16,000 KRW, up 2.56% from the previous day. This is a 20.2% decrease compared to September 16. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net buyers of 60,349 shares. Over the past five days, individual investors have been net sellers of 168,714 shares, while foreigners and institutions have been net buyers of 222,876 shares and net sellers of 59,355 shares, respectively.

On October 16, Pharmicell became an issue in the market due to the announcement by WHO that Remdesivir is 'ineffective,' which led to a decline.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.